Project Orbis Led To 80% Cut In Submission Gap For Cancer Drugs In Switzerland

The international Project Orbis regulatory collaboration initiative reduced the submission gap between filings made in the US and Switzerland even more than expected, marking a step towards faster access to innovative cancer drugs, regulatory experts have told the Pink Sheet.